Posts in the “Early Detection Early Detection” category:

Advancing the development of new “targeted drug therapies” by enhancing the science of biomarkers

Posted by Samantha Powell on October 3rd, 2014 |

A key area of new drug development lies in the field of targeted therapies, sometimes called “personalized medicines,” which are drugs tailored to the genetic makeup of individual patients. These drugs are called targeted therapy because health care professionals can use clinical test results from a patient to select a specific drug that has a… Read More

Call Widens for Medicare CT Lung Cancer Screening Coverage

Posted by Samantha Powell on September 30th, 2014 |

More than 60 patient advocacy and medical organizations have joined a coalition headed by the Lung Cancer Alliance, the American College of Radiology and The Society of Thoracic Surgeons, in urging Medicare to cover low dose computed tomography (LDCT) screening for beneficiaries at high risk for lung cancer. In a new joint letter to the… Read More

Screening may detect lung cancer at its earliest stages

Posted by Samantha Powell on September 25th, 2014 |

A lung cancer screening method that is recommended for long-term smokers, whether they have quit or not, promises to detect cancer at its earliest and most curable stages. However, most insurance does not cover the cost, and participation has been limited. To raise awareness of the screening and its potential, West Penn Hospital is now… Read More

Lung Infections May Hamper Ability to Detect Lung Cancer

Posted by Samantha Powell on September 23rd, 2014 |

A test used to diagnose lung cancer may not be as reliable in geographic regions where certain lung infections are more common, a new analysis says. One noninvasive way of detecting lung cancer is through the use of what’s known as functional imaging. For lung cancer, a specific type of functional imaging called FDG-PET is… Read More

A Cancer Battle We Can Win

Posted by Samantha Powell on September 21st, 2014 |

THE war against cancer can be confusing, with providers, insurers and policy makers debating the effectiveness of treatments, prevention programs and research. But there is one significant victory within our grasp. There is, increasingly, a consensus that CT screening for lung cancer can save thousands of lives each year. Lung cancer, the No. 1 cancer… Read More

Evidence Mounts Supporting Medicare Coverage of Lung Cancer Screening

Posted by Samantha Powell on September 19th, 2014 |

The stockpile of evidence confirming — and reconfirming — the lifesaving value of lung cancer screening continues to grow. The latest study, published in the Annals of Internal Medicine, reexamines all the data from the 53,000 participant National Lung Screening Trial (NLST), and looks specifically at the impact of computed tomography (CT) screening on high… Read More

Local Doctors Discover New Way to Light Up Hard To Find Cancer

Posted by Samantha Powell on September 17th, 2014 |

Invisible cancer, it’s a killer. Now local researchers have found a way to see what until now has been undetectable cancer. 3 On Your Side Health Reporter Stephanie Stahl has more on what’s being called a game changer. A special green glow could light up the future of cancer therapy. “I feel like I’m a… Read More

Treatment For Lung Cancer May Depend On Your DNA

Posted by Samantha Powell on September 16th, 2014 |

The Northside Hospital Cancer Institute (NHCI), Atlanta, has announced it will participate in a unique National Cancer Institute clinical collaboration to treat lung cancer based on a patient’s genetic profile, becoming the first to offer the clinical trial known as Lung-MAP. The study is a multi-drug, multi-arm, biomarker-driven clinical trial for patients with advanced squamous… Read More

Lifestyle and genetics strongly impact biomarkers for inflammation and cancer

Posted by Samantha Powell on September 16th, 2014 |

Genetics and lifestyle are determining factors for protein levels in the bloodstream, according to a new study. This discovery greatly influences the possibilities for using more biomarkers to identify disease. This finding came from a large-scale study of the significance of genetic, clinical, and lifestyle factors on protein levels in the bloodstream. It was conducted… Read More

Elderly Get Most Benefit, Harm From Lung Cancer Screening

Posted by Samantha Powell on September 9th, 2014 |

A new analysis of the National Lung Screening Trial (NLST) showed that both benefits and harms of low-dose computed tomography (LDCT) screening are slightly greater among patients older than 65 years. This suggests that excluding elderly patients from screening is probably not warranted. “The primary source of evidence for LDCT effectiveness was the NLST, and… Read More